Hermetica Superfood Encyclopedia
The Short Answer
Minthostachys acris produces an essential oil dominated by pulegone and related monoterpene ketones that exert bronchodilatory, antimicrobial, and mucolytic effects through modulation of smooth muscle tone and inhibition of microbial membrane integrity. Phytochemical analysis of aerial parts from Cuzco identified 59 volatile compounds, and the genus-level evidence positions pulegone-rich fractions as the primary drivers of the herb's traditional respiratory applications in Andean ethnomedicine.
CategoryHerb
GroupSouth American
Evidence LevelPreliminary
Primary KeywordMinthostachys acris benefits
Minthostachys acris — botanical close-up
Health Benefits
**Respiratory Support**
The pulegone-rich essential oil is traditionally employed to relieve bronchospasm and facilitate mucus clearance, with genus-level evidence suggesting smooth muscle relaxation and expectorant activity consistent with its Andean use for coughs and altitude-related respiratory complaints.
**Antimicrobial Activity**
Essential oils from Minthostachys species exhibit broad-spectrum antimicrobial properties attributable to pulegone and menthone, which disrupt bacterial and fungal cell membrane integrity, supporting the herb's role in treating respiratory and gastrointestinal infections in traditional Andean medicine.
**Gastrointestinal Relief**
Closely related Minthostachys species are among the most widely used phytotherapeutic resources in Andean countries for gastrointestinal disorders, with carminative, antispasmodic, and digestive properties linked to the monoterpene ketone fraction of the essential oil.
**Anti-inflammatory Potential**: Research on M
verticillata demonstrates NF-κB pathway suppression and reduced IL-8 production in intestinal cell lines, and polyphenolic constituents including rosmarinic acid and chlorogenic acid common across the genus likely contribute analogous anti-inflammatory effects in M. acris.
**Antioxidant Properties**
Lamiaceae herbs in the Minthostachys genus contain rosmarinic acid, rutin, and chlorogenic acid, all well-characterized radical scavengers that protect cells from oxidative stress via electron donation and metal chelation mechanisms.
**Intestinal Barrier Protection**: M
verticillata extracts prevented decreases in transepithelial electrical resistance and reduced FITC-dextran permeability in Caco-2 monolayer models, suggesting genus-wide potential for protecting intestinal epithelial integrity relevant to gut health applications.
**Mucolytic and Expectorant Effects**
Pulegone and menthone, the dominant volatile compounds in the Minthostachys genus, interact with airway epithelium to promote secretion thinning and ciliary clearance, providing a mechanistic rationale for the herb's use as muña or a muña-like remedy in altitude-affected Andean populations.
Origin & History
Natural habitat
Minthostachys acris is a native Andean aromatic herb belonging to the Lamiaceae family, growing primarily in the high-altitude regions of Peru, including Cuzco, at elevations characteristic of the Andean puna and quechua zones. Like other members of the Minthostachys genus, it thrives in cool, mountainous climates with well-drained soils and is cultivated or wildcrafted alongside related species such as M. mollis and M. verticillata across Bolivia, Argentina, Ecuador, and Colombia. The plant's aerial parts yield a volatile essential oil rich in monoterpene ketones, and it has been harvested by Andean communities for generations as both a culinary seasoning and medicinal herb.
“Minthostachys acris belongs to a genus whose members, collectively referred to as 'muña' or 'muña muña' in Quechua-speaking Andean communities, have been integral to Andean medicinal and culinary traditions for centuries, with documented use spanning Peru, Bolivia, Ecuador, Argentina, and Colombia. The broader Minthostachys genus is classified as one of the most widely used phytotherapeutic resources in Andean countries, particularly for gastrointestinal complaints including indigestion, flatulence, and intestinal infections, and for respiratory conditions exacerbated by high-altitude hypoxia. Andean communities have traditionally prepared muña-type species as infusions, added to boiling stews as a food preservative and digestive aid, and applied topically as poultices for musculoskeletal pain, reflecting the deep integration of the plant into highland foodways and medicine. The Inca civilization and subsequent Andean cultures recognized the aromatic Lamiaceae herbs of this genus as sacred and medicinal, and their use continues uninterrupted in contemporary Andean ethnomedicine, particularly in Peru's Cuzco region where M. acris is specifically documented.”Traditional Medicine
Scientific Research
Direct clinical or experimental evidence for Minthostachys acris specifically is extremely limited; one phytochemical study identified 59 volatile compounds in the essential oil from aerial parts cultivated in Cuzco, Peru, but detailed compositional data and biological activity results from that study are not widely available in the indexed literature. The preponderance of mechanistic evidence is extrapolated from in vitro studies on the closely related M. verticillata, which demonstrated NF-κB inhibition, reduced IL-8 secretion, and intestinal barrier protection in HT-29 and Caco-2 cell line models with high IC50 values suggesting a favorable safety window. No human clinical trials, randomized controlled studies, or pharmacokinetic investigations have been published specifically for M. acris, and the broader genus-level phytochemical literature consists predominantly of essential oil compositional analyses and small-scale in vitro antimicrobial assays without standardized methodology. Overall, the evidence base remains at the preclinical and ethnobotanical level, and claims of clinical efficacy cannot be made with confidence absent controlled human studies.
Preparation & Dosage
Traditional preparation
**Traditional Herbal Tea (Infusion)**
250 mL cup, consumed 2–3 times daily for respiratory or digestive complaints per Andean traditional practice
Dried aerial parts steeped in boiling water for 5–10 minutes; 1–2 teaspoons of dried herb per .
**Essential Oil (Aromatherapy/Topical)**
Extracted by steam distillation from aerial parts; used in diluted form (1–3% in carrier oil) for topical application or diffused for respiratory inhalation; internal essential oil use requires clinical supervision due to pulegone hepatotoxicity risk at high doses.
**Dried Herb (Culinary/Condiment)**
Used as a culinary seasoning in Andean cuisine, providing incidental phytochemical exposure; no standardized culinary dose established.
**Hydroalcoholic Extract (Tincture)**
No commercially standardized tincture exists for M. acris specifically; related Minthostachys species are prepared as 1:5 tinctures in 40–60% ethanol in regional herbal practice.
**Standardization**
No commercial standardization to pulegone or polyphenol content has been established for M. acris; genus-level essential oil pulegone content ranges 16–41% across species and collection sites.
**Timing Notes**
Traditional use favors consumption with meals for gastrointestinal applications and before sleep or during cold exposure for respiratory benefits; no pharmacokinetic data exist to guide precise dosing intervals.
Nutritional Profile
As an aromatic herb consumed primarily in infusion or as a condiment, Minthostachys acris contributes negligible macronutrients at typical use quantities. The principal phytochemical fraction is the volatile essential oil, constituting a significant proportion of the aerial parts' dry weight, and dominated by monoterpene ketones including pulegone (estimated 16–41% of oil based on genus data), menthone, and neomenthol, along with minor sesquiterpenes. Polyphenolic constituents characteristic of the Lamiaceae family and documented in related species include rosmarinic acid, chlorogenic acid, salvianolic acids, rutin, and quercetin-3-O-glucoside, all with established antioxidant bioactivity; rosmarinic acid bioavailability from Lamiaceae infusions is moderate, with human studies on rosemary and sage reporting plasma concentrations following oral ingestion. The herb also provides trace minerals and dietary fiber when consumed as a whole herb preparation, though these contributions are minor relative to standard dietary sources.
How It Works
Mechanism of Action
The primary bioactive fraction of Minthostachys acris is its volatile essential oil, in which pulegone and menthone function as monoterpene ketones that modulate smooth muscle contractility through calcium channel interference and stimulation of TRPM8 cold-receptor pathways, producing bronchodilatory and antispasmodic effects in the respiratory and gastrointestinal tracts. At the molecular level, extrapolating from M. verticillata research, polyphenolic constituents such as rosmarinic acid inhibit the ADAM-17/EGFR/Akt/GSK-3β signaling axis, while chlorogenic acid modulates VEGFR2, ERK1/2, and Akt signaling, collectively reducing pro-inflammatory cytokine production and cell migration. NF-κB pathway suppression by polyphenol fractions attenuates TNF-α-induced transcription of inflammatory mediators including IL-8, providing mechanistic grounding for anti-inflammatory and mucosal-protective effects. The antimicrobial activity of pulegone is mediated through disruption of microbial membrane phospholipid bilayers and inhibition of membrane-associated enzymatic processes, while antioxidant polyphenols donate hydrogen atoms to neutralize reactive oxygen species via standard HAT and SET mechanisms.
Clinical Evidence
No clinical trials have been conducted specifically on Minthostachys acris, and the ingredient lacks human pharmacokinetic, efficacy, or safety data from controlled investigations. Evidence from the broader Minthostachys genus is limited to in vitro cell culture experiments, principally with M. verticillata, which demonstrated concentration-dependent NF-κB suppression and intestinal barrier protection without reporting human-relevant effect sizes or clinically translatable endpoints. Traditional ethnobotanical documentation from Andean communities provides the strongest practical evidence base, recording consistent use of muña-type Minthostachys species for respiratory and gastrointestinal complaints across multiple Andean nations for centuries. Until prospective human studies with standardized preparations are conducted, confidence in specific clinical outcomes remains low, and therapeutic applications are supported only by mechanistic plausibility and traditional use.
Safety & Interactions
Minthostachys acris lacks formal human safety studies, and its safety profile must be inferred from genus-level data and the known toxicology of its dominant volatile constituent, pulegone, which at high doses is a documented hepatotoxin metabolized to the reactive intermediate menthofuran via CYP2E1, causing hepatocellular damage in animal models and rare human cases of pennyroyal oil poisoning. At typical culinary and traditional infusion doses, the herb is presumed safe based on centuries of Andean use without documented adverse events, and in vitro studies on M. verticillata showed high IC50 values in intestinal cell models; however, concentrated essential oil preparations should be used with extreme caution and avoided internally without clinical supervision. Pulegone-containing herbs are contraindicated during pregnancy due to potential uterotonic and abortifacient effects documented for high-dose pennyroyal (Mentha pulegium), and lactating women should also avoid essential oil preparations. Potential drug interactions include theoretical potentiation of hepatotoxic medications due to shared CYP2E1 metabolism and possible additive effects with anticoagulants given polyphenol content, though no interaction data specific to M. acris have been published.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Minthostachys acrismuñamuña muñaAndean mintPeruvian muña
Frequently Asked Questions
What is Minthostachys acris used for traditionally?
Minthostachys acris is used in Andean traditional medicine primarily for respiratory complaints such as coughs, bronchial congestion, and altitude-related breathing difficulties, as well as for gastrointestinal disorders including indigestion and flatulence. It belongs to the muña group of Andean herbs, which are among the most widely used medicinal plants across Peru, Bolivia, Ecuador, and Argentina, prepared mainly as herbal infusions from the dried aerial parts.
What bioactive compounds are found in Minthostachys acris?
The essential oil from the aerial parts of Minthostachys acris, collected in Cuzco, Peru, has been found to contain 59 volatile compounds, though individual concentrations have not been fully published. Based on genus-level data, the oil likely contains pulegone (16–41%), menthone, and neomenthol as dominant constituents, along with polyphenols such as rosmarinic acid and chlorogenic acid characteristic of the Lamiaceae family.
Is Minthostachys acris the same as muña?
Minthostachys acris is one of several species within the Minthostachys genus collectively referred to as 'muña' or 'muña muña' in Quechua-speaking Andean communities, alongside M. mollis and M. verticillata. While all these species share similar aromatic profiles and traditional uses, they are botanically distinct, and the specific phytochemical composition of M. acris may differ from more studied species such as M. mollis, which is the most commonly commercialized muña.
Are there any safety concerns or side effects with Minthostachys acris?
The primary safety concern for Minthostachys acris centers on its pulegone content, as high doses of pulegone are hepatotoxic, metabolized to the reactive compound menthofuran via CYP2E1 in the liver. Traditional infusion preparations at culinary doses are generally considered safe based on long-term Andean use, but concentrated essential oil preparations should be avoided during pregnancy due to potential uterotonic effects, and internal essential oil use should not be undertaken without medical supervision.
How do you prepare Minthostachys acris as an herbal tea?
The traditional Andean preparation involves steeping 1–2 teaspoons of dried Minthostachys acris aerial parts in 250 mL of freshly boiled water for 5–10 minutes, then straining and consuming the infusion 2–3 times daily. The infusion is commonly used warm to maximize inhalation of the volatile essential oil fraction during consumption, which enhances the respiratory mucolytic and bronchodilatory effects attributed to the herb.
What is the difference between Minthostachys acris essential oil and leaf extracts for respiratory support?
Minthostachys acris essential oil, rich in pulegone, provides rapid inhalation-based bronchospasm relief and expectorant effects suited for acute respiratory complaints, while leaf extracts offer a milder, sustained approach better for chronic use. Essential oils are typically more concentrated and volatile, making them ideal for steam inhalation or diffusion, whereas extracts can be taken as tea or tincture with gentler absorption. The choice depends on whether you need immediate respiratory symptom relief or consistent daily respiratory support.
Who should avoid Minthostachys acris, and are there specific populations at higher risk?
Pregnant and nursing women should avoid Minthostachys acris due to pulegone content, which has traditionally been associated with uterine stimulation concerns, and individuals with liver sensitivity or those taking hepatotoxicity-risk medications should exercise caution. People with asthma triggered by strong volatile compounds may experience irritation from essential oil inhalation rather than benefit. Those with allergies to the Lamiaceae family (mint family) should consult a practitioner before use.
How does clinical research on Minthostachys acris compare to traditional Andean use for altitude-related respiratory issues?
While traditional Andean communities have used Minthostachys acris (muña) for centuries to manage high-altitude respiratory complaints and bronchospasm, modern clinical trials remain limited, with most evidence derived from in vitro antimicrobial studies and genus-level pharmacological data rather than human trials. The mechanism of action—pulegone-induced smooth muscle relaxation and mucus clearance—aligns with traditional applications, but rigorous human studies specifically validating altitude acclimatization benefits are lacking. Current evidence supports the ingredient's plausibility for respiratory support but highlights the need for double-blind controlled trials to establish efficacy claims.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w minthostachys-acris-minthostachys-acris curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
